Estimating Hypothetically Negotiated Royalty Rates After MedImmune, Inc. v Genentech, Inc. et al
$25.00v14i3: pp. 43-52 Stenan D. Porter Antitrust 2008
Showing all 2 results

v14i3: pp. 43-52 Stenan D. Porter Antitrust 2008

v15i1: pp. 93-104 David Boyd; Thomas R. Ireland Antitrust 2008
Millo v. Delius and Losses that Are ‘‘Not Otherwise Compensable’’
1 × $25.00
Trends in Legal Decisions Involving Hedonic Damages from July 2, 2022 to July 1, 2024
1 × $25.00
Single equation models for valuing economic loss
1 × $25.00 Subtotal: $75.00